Dopamine ?-hydroxylase (N-Term; human) Polyclonal Antibody

CAT N°: 10009371
Price:

680.00 578.00

Dopamine ?-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson’s disease, and drug abuse. The expression of DBH is also elevated during stress.

Territorial Availability: Available through Bertin Technologies only in France

  • Correlated keywords
    • antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson’s diseases drugs abuse immunoblotting
  • Product Overview:
    Dopamine ?-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson’s disease, and drug abuse. The expression of DBH is also elevated during stress.

We also advise you